One recurring argument that Bayer Corp. has made in the swarm of cases claiming that Roundup causes cancer is that federal law concerning the product’s warning label should preempt state law claims that the company failed to warn consumers.

Those arguments have so far been unsuccessful in persuading state and federal trial courts in California, home of the lion’s share of the trial court action in Roundup cases thus far. The company currently has appeals pending on the preemption issue before the Ninth Circuit and California Court of Appeal.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]